BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long Covid
biovie宣佈FDA授權進行第2期臨床試驗,評估Bezisterim在長病毒中的效果
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long Covid
biovie宣佈FDA授權進行第2期臨床試驗,評估Bezisterim在長病毒中的效果
譯文內容由第三人軟體翻譯。